Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 3 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 11/19/2012 3:12:29 PM : Outperform Start Price: $41.33 VRTX Score: -6.38

May be very worth the speculation at this price

Featured Broker Partners


Advertisement